Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rachita Navara

Clinical Cardiac Electrophysiology San Rafael, CA Medical Doctor

NPI 1740675115 CMS profile 5703056

813 D St, Ste 3, San Rafael, CA 94901

Open in the dashboard

General payments

$81,840

506 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rachita Navara of San Rafael, CA is reported in the CMS Open Payments database as having received $81,840 across 506 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $140 1
2024 General $9,348 57
2023 General $34,087 248
2022 General $12,391 114
2021 General $17,210 20
2020 General $2,750 21
2019 General $5,914 45

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rachita Navara
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Rachita Navara were reported at $140. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Rachita Navara Clinical Cardiac Electrophysiology median Middle half National median
2019 $5,914 $2,361 $585–$8,260 $163
2020 $2,750 $993 $247–$4,351 $114
2021 $17,210 $1,185 $326–$4,739 $132
2022 $12,391 $2,073 $554–$6,789 $149
2023 $34,087 $2,568 $759–$8,159 $160
2024 $9,348 $2,557 $703–$7,403 $164
2025 $140 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $26,086 197 payments
  2. Abbott Laboratories $20,811 159 payments
  3. Boston Scientific Corporation $16,557 15 payments
  4. Medtronic Vascular, Inc. $7,573 56 payments
  5. Atricure, Inc. $4,933 34 payments
  6. Biotronik Inc. $4,177 27 payments
  7. Medical Device Business Services, Inc. $1,113 7 payments
  8. Biosense Webster, Inc. $248 6 payments
  9. Medtronic USA, Inc. $191 4 payments
  10. Baxter Healthcare $149 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $44,349 198 payments
  2. Food and Beverage $18,783 294 payments
  3. Grant $15,500 2 payments
  4. Education $1,413 9 payments
  5. Consulting Fee $1,045 2 payments
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $750 1 payment
Products named General payments · program years 2019–2025
  1. EMBLEM S ICD ELECTRODE DELIVERY SYSTEM $15,000 1 payment
  2. ENSITE PRECISION $13,567 96 payments
  3. Micra $4,593 33 payments
  4. SYNERGY ABLATION SYSTEM $3,552 20 payments
  5. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $3,498 20 payments
  6. ENSITE $2,198 26 payments
  7. TACTICATH ABLATION CATHETER, SENSOR ENABLED $2,152 12 payments
  8. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $2,117 6 payments
  9. Carto 3 $1,362 13 payments
  10. ARCTIC FRONT ADVANCE $1,187 9 payments
  11. Other $8,363 74 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

27

Median for Cardiology: 2,533

Drug cost

$373

Median for Cardiology: $485,213

Branded share of claims

100%

Median for Cardiology: 25.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Sotalol Sotalol Hcl Brand 27 $373

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,782 Part D prescribers listed as Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$71,225

Medicare's payments for the services billed

Medicare patients

65

Average age 76

Services billed

333

30 women, 35 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 57%
Ischemic heart disease 54%
Heart failure 52%
Arthritis 48%
Diabetes 46%
Chronic kidney disease 46%
Depression 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

506 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record